Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
NuVera Medical is a medical device company
KSQ Therapeutics is using CRISPR technology within a powerful drug discovery engine to enable high-confidence drug development.
MabSpace Biosciences is a biotech company focused on discovery & development of innovative antibody based therapeutics for cancer.
Veritas Genetics is a provider of a genetic testing platform intended to empower people to live healthier and longer.
Hitales is an internet company that develops applications of medical artificial intelligence products.
360 Health provide health care and life science services to clients in China.
Lilly Asia Ventures has invested in 102 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Lilly Asia Ventures's top investment sectors include Medical, Biotechnology, Health Diagnostics, Health Care, Personal Health. The firm invests across 15 different industry categories.
Among tracked funding rounds, KSQ Therapeutics received $80.0M in a Series C round. Lilly Asia Ventures's total known invested capital is $8.3B.
Lilly Asia Ventures's average investment size is $103.5M across its portfolio of 102 companies.